Erwin Surmann

UCB Pharma (Germany) — Germany

Medicine · Health Sciences

15h-index1.2kcitations26works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(22), Neurological disorders and treatments(11), Botulinum Toxin and Related Neurological Disorders(10), Restless Legs Syndrome Research(5), Attention Deficit Hyperactivity Disorder(4)

Publications25 total

Pharmacokinetics, Tolerability, and Bioequivalence of Two Formulations of Rotigotine in Healthy Chinese Subjects
Clinical Therapeutics·2018· 5 cited
Rotigotine transdermal patch in Chinese patients with advanced Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study
Parkinsonism & Related Disorders·2017· 24 cited
Corrigendum to “Rotigotine transdermal patch in Chinese patients with early Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study” [Park. Relat. Disord. 28 (2016) 49–55]
Parkinsonism & Related Disorders·2017· 3 citedOpen Access
Issue Information
The Journal of Clinical Pharmacology·2016Open Access
Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease
BMC Neurology·2016· 57 citedOpen Access
Rotigotine transdermal patch in Chinese patients with early Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study
Parkinsonism & Related Disorders·2016· 28 cited
A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease-Associated Chronic Pain
The Journal of Clinical Pharmacology·2015· 107 citedOpen Access
Rotigotine in Patients with PD and Unsatisfactory Early-morning Motor Symptom Control: a Post-hoc Analysis of Efficacy and Safety by Dose (P1.190)
Neurology·2015
Effects of long-term treatment with rotigotine transdermal system on dyskinesia in patients with early-stage Parkinson's disease
Parkinsonism & Related Disorders·2014· 24 cited
Rotigotine transdermal system and evaluation of pain in patients with Parkinson’s disease: a post hocanalysis of the RECOVER study
BMC Neurology·2014· 63 citedOpen Access
A Randomized Study of Rotigotine Dose Response on ‘Off’ Time in Advanced Parkinson's Disease
Journal of Parkinson s Disease·2014· 45 citedOpen Access
Associations between Severity of Motor Function and Nonmotor Symptoms in Parkinson's Disease: A Post Hoc Analysis of the RECOVER Study
European Neurology·2014· 16 citedOpen Access
Rotigotine and specific non-motor symptoms of Parkinson's disease: Post hoc analysis of RECOVER
Parkinsonism & Related Disorders·2013· 158 cited
The safety and tolerability of rotigotine transdermal system over a 6-year period in patients with early-stage Parkinson’s disease
Journal of Neural Transmission·2013· 35 cited
Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER
Journal of Neural Transmission·2012· 57 citedOpen Access
Rotigotine transdermal system for the management of motor function and sleep disturbances in Parkinson’s disease: Results from a 1-year, open-label extension of the RECOVER study
Basal Ganglia·2012· 29 citedOpen Access
Rotigotine Transdermal System Improves Neuropsychiatric Features (Apathy, Anhedonia, Anxiety, and Depression) and Fatigue in Patients with Parkinson's Disease: A Post-Hoc Analysis of Five Double-Blind Placebo-Controlled Studies (P06.088)
Neurology·2012· 1 cited
Lacosamide Has No Effect on the Enzymatic Activity of CYP3A4 (P01.076)
Neurology·2012· 4 cited
Rotigotine Transdermal System Improves Pain in Patients with Parkinson's Disease: A Post-Hoc Analysis of Patients Reporting Pain in the RECOVER Study (P06.085)
Neurology·2012
Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson’s disease: A prospective, open-label extension study
Parkinsonism & Related Disorders·2012· 52 cited
page 1 of 2Next →

Frequent Co-authors

Babak Boroojerdi(13), Lars Bauer(9), К. Ray Chaudhuri(8), Mahnaz Asgharnejad(8), Claudia Trenkwalder(6), John Whitesides(6), L. Ghys(6), Joseph H. Friedman(4), Bryan Kies(3), D. Hill(3), Jan Kassubek(3), Olivier Rascol(3), Elisabeth Dohin(3), Zhenxin Zhang(3), Monika Rudzińska(2), Jennifer Fine(2), Péter Diószeghy(2), Tim Anderson(2), Marco Zucconi(2), Eduardo Tolosa(2)